Tara Biosystems nabs $10m Series A2

New York City-based Tara Biosystems, Inc., a provider of predictive cardiac physiology, has raised $10 million in Series A2 financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this